Latest news with #PMCKBhd
New Straits Times
09-07-2025
- Business
- New Straits Times
PMCK makes steady ACE Market debut, opens 2.3pct above IPO price
KUALA LUMPUR: Private healthcare provider PMCK Bhd made a steady debut on the ACE Market of Bursa Malaysia, opening half a sen or 2.3 per cent higher from its initial public offering (IPO) price of 22 sen. The stock opened at 22.5 sen and touched a high of 23.5 sen in early trade. It was the most actively traded counter with over 36 million shares changing hands. The IPO entails a public issue of 272.6 million new shares, along with an offer for sale of 32.7 million existing shares via private placement. The company, which provides a range of specialist and outpatient healthcare services, raised RM59.97 million from its IPO exercise to fund the expansion of its medical facilities, acquisition of medical equipment and working capital.
The Star
30-06-2025
- Business
- The Star
PMCK IPO oversubscribed 1.87 times ahead of ACE Market listing on July 9
KUALA LUMPUR: PMCK Bhd's initial public offering (IPO) has been oversubscribed by 1.87 times for the Malaysian public portion, ahead of its listing on the ACE Market of Bursa Malaysia on July 9. The company said it has received a total of 2,512 applications for 156.25 million IPO shares worth RM34.37 million from the Malaysian public, which represented an overall oversubscription rate of 1.87 times. "For the Bumiputera public portion, a total of 993 applications for 23.09 million IPO shares were received, where the balance has been clawed back and re-allocated to the public (portion),' it said in a media statement. PMCK said 43.62 million IPO shares made available for application by the eligible persons have also been fully subscribed, while 136.32 million IPO shares by way of private placement to Bumiputera investors approved by MITI have been fully placed out after applying the relevant clawback and reallocation provisions as set out in PMCK's prospectus. "Furthermore, 38.12 million IPO shares and 32.72 million existing shares by way of private placement to selected investors have been fully placed out,' it added. The notices of allotment will be posted to all successful applicants on July 7, 2025. - Bernama
The Star
20-06-2025
- Business
- The Star
PMCK poised for growth with IPO plans
PETALING JAYA: PMCK Bhd, a private healthcare provider enroute to listing on the ACE Market of Bursa Malaysia, intends to pay at least 20% of its net profit as a dividend going forward. TA Research assumes a dividend payout of 20% to 44% across financial year 2025 (FY25) to FY27 and projects forward yields to be at 1.3% to 2.1%. TA Research said for its initial public offering (IPO) price of 22 sen a share, PMCK is priced at a trailing price earnings ratio (PE) of 15.9 times based on FY24 earnings per share (EPS). The research house forecast a target PE of 16 times FY26 EPS for the counter, while deriving a fair value of 23 sen a share. PMCK is operating the Putra Medical Centre in Alor Setar, Kedah and has been in the business for over 30 years, offering specialist consultant services and clinical support, with 40 consultants across 17 specialisations. PMCK will raise RM60mil through its IPO on Bursa Malaysia. It wants to strengthen its presence in northern Malaysia to attract patients and drive long-term revenue growth. Thus far, Kedah has one of the lowest private hospital bed densities in Malaysia, highlighting a significant gap in private healthcare access. As part of its expansion, PMCK is constructing a new medical centre, PMC Kulim, with operations targeted to start by the first quarter of financial year 2028 (1Q28). The 12-storey private medical centre comes with a seven-storey mixed development comprising a four-storey hotel with a two-storey food court and carparks. PMCK will consolidate the RYM DX Laboratory Sdn Bhd (medical lab) into PMC Kulim by 1Q28 to cater to increasing demand for diagnostic services. It will upgrade the equipment and facilities in PMC Kedah under clinical support services (medical lab) and facilities services (radiology unit). TA Research projects net profit to contract by 24.8% to RM11.3mil in FY25, as it expects patient numbers to drop by 20% due to the flooding in Alor Setar and surrounding areas, which hindered patient access. It expects the profit after tax margin to decline to 12.1% (versus 14.4% in FY24) due to softer patient volumes and higher administrative expenses as PMCK's facilities remained fully operational during the heavy rainfall between September and December 2024.
New Straits Times
26-05-2025
- Business
- New Straits Times
Alor Setar-based PMCK to raise nearly RM60mil from ACE Market IPO
KUALA LUMPUR: Private healthcare service provider PMCK Bhd aims to raise RM59.97 million from its initial public offering (IPO) ahead of a planned listing on the ACE Market of Bursa Malaysia on July 9. The IPO entails a public issue of 272.6 million new shares at an issue price of 22 sen each, alongside an offer for sale of 32.7 million existing shares via private placement, according to the company's prospectus launched today. Based on the enlarged share capital of 1.09 billion shares at the IPO price, PMCK is expected to have a market capitalisation of approximately RM239.93 million upon listing. Of the public issue, 54.53 million shares are allocated to the Malaysian public, 43.62 million to eligible directors, employees and contributors to the group's success, 136.33 million to approved Bumiputera investors, and 38.12 million to selected investors. Founded in Alor Setar, PMCK operates a 121-bed private medical centre offering specialist consultant services, inpatient and outpatient care, clinical diagnostics and pharmacy services. It also runs dental and polyclinic facilities, along with a medical laboratory business under RYM DX Lab. PMCK is optimistic about its growth prospects, underpinned by plans to expand its presence in Kedah through a new 12-storey private medical centre in Kulim. The group also intends to upgrade medical equipment at its existing Alor Setar facility and consolidate its ancillary operations for greater efficiency. It expects demand for private healthcare to remain resilient, supported by demographic shifts, increasing insurance coverage and a shortage of hospital beds in the northern region. In 2024, the group recorded RM104.3 million in revenue, with more than 75 per cent contributed by inpatient services. Proceeds from the IPO will be used to repay borrowings, acquire medical equipment, fund renovations and expansion, and cover working capital and listing-related expenses. Malacca Securities is the principal adviser, sponsor, underwriter and joint placement agent, while Kenanga Investment Bank is a joint placement agent. Applications for the public tranche open today and will close at 5pm on June 25.
The Star
07-05-2025
- Business
- The Star
ACE Market-bound PMCK inks underwriting agreement
From left: PMCK Bhd managing director Datuk Lee Gaik Cheng, PMCK deputy executive chairman Datuk Dr Lim Kim Huat, Malacca Securities Sdn Bhd managing director Lim Chia Wei and Malacca Securities vice-president, corporate finance Tan Sin Jiang. KUALA LUMPUR: PMCK Bhd has inked an underwriting agreement with Malacca Securities Sdn Bhd for its initial public offering (IPO) on the ACE Market of Bursa Malaysia, scheduled for the third quarter of 2025. In a statement yesterday, the private healthcare service provider said the IPO comprised the issuance of 272.60 million new shares and an offer for sale of 32.72 million existing shares. 'Of the 272.60 million new shares, 54.53 million will be made available to the Malaysian public through balloting, and 43.62 million to eligible directors and employees, as well as persons who have contributed to the success of the company. 'Meanwhile, 136.33 million shares are reserved for private placement to selected bumiputra investors approved by the Investment, Trade and Industry Ministry, and 38.12 million shares by way of private placement to selected investors,' it said. Pursuant to the underwriting agreement, Malacca Securities will underwrite a total of 98.15 million shares, which include 54.53 million shares made available to the Malaysian public and 43.62 million shares allocated to eligible persons. It said PMCK plans to utilise the proceeds from its IPO for several strategic purposes, including the repayment of bank borrowings, particularly those incurred for the construction of Putra Medical Centre Kulim (PMC Kulim). 'PMC Kulim is designed with a focus on expanding clinical support services, particularly in outpatient care, to meet the evolving needs of the community,' it said. Managing director Datuk Lee Gaik Cheng said over the past 30 years, it has grown to become a recognised name. — Bernama
